Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

M&A/IPOs

 

Cinven looks to take Synlab private as Covid boost falters

Frankfurt-listed Synlab could be about to be taken private following a non-binding full takeover offer earlier this week. With its full year results released yesterday and facing questions about its plans, HBI asks market experts what they think of the move.
March 17, 2023

Cinven looking to take Synlab private

London headquartered global PE firm Cinven has submitted a non-binding offer to fully take over Europe's largest lab group Synlab, the company confirmed today, following speculation it was looking to take the group private.
March 13, 2023

FutureLife acquires again in Spain

Czechia-based fertility group FutureLife continues to expand in Spain with its latest acquisition. HBI chats with a European fertility operator to find out what is making the Spanish market appealing to investors.
March 10, 2023

Merger strengthens Medigold’s occupational health offering

Medigold, one of the UK’s largest occupational health care providers, is acquiring Health Management, a major competitor, in a deal that will make it the UK's largest provider of occupational health in terms of number of employees covered.
March 10, 2023

KPJ Healthcare exiting Indonesia citing rules imposed on foreign operators

KPJ Healthcare Bhd, Malaysia’s second largest for-profit hospital group by revenue, is to sell its Indonesian hospital operations to rival Columbia Asia Healthcare. This will mark its exit from the country. Luxembourg-based PE firm CVC Capital Partners is reportedly considering buying a minority stake in the group.
March 7, 2023

Biggest hospital chain in Philippines may IPO for $1bn

Metro Pacific Hospitals, the Philippines' most expansive hospital chain with 12 hospitals and seven medical centres across the country, is considering going public at a valuation of up to $1bn in a revival of a plan that was initially shelved in 2019, according to reports.
March 3, 2023

Fresenius to deconsolidate FMC

Michael Sen, the new CEO of multinational health care conglomerate Fresenius, is making preparations to deconsolidate struggling dialysis subsidiary Fresenius Medical Care (FMC). The plans fall short of full divestment and may not be radical enough to appease investors.
February 10, 2023
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us